Correlation Between THC Therapeutics and Flowr Corp
Can any of the company-specific risk be diversified away by investing in both THC Therapeutics and Flowr Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining THC Therapeutics and Flowr Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between THC Therapeutics and Flowr Corp, you can compare the effects of market volatilities on THC Therapeutics and Flowr Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in THC Therapeutics with a short position of Flowr Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of THC Therapeutics and Flowr Corp.
Diversification Opportunities for THC Therapeutics and Flowr Corp
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between THC and Flowr is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding THC Therapeutics and Flowr Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Flowr Corp and THC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on THC Therapeutics are associated (or correlated) with Flowr Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Flowr Corp has no effect on the direction of THC Therapeutics i.e., THC Therapeutics and Flowr Corp go up and down completely randomly.
Pair Corralation between THC Therapeutics and Flowr Corp
If you would invest 0.30 in THC Therapeutics on September 14, 2024 and sell it today you would lose (0.23) from holding THC Therapeutics or give up 76.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 79.69% |
Values | Daily Returns |
THC Therapeutics vs. Flowr Corp
Performance |
Timeline |
THC Therapeutics |
Flowr Corp |
THC Therapeutics and Flowr Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with THC Therapeutics and Flowr Corp
The main advantage of trading using opposite THC Therapeutics and Flowr Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if THC Therapeutics position performs unexpectedly, Flowr Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Flowr Corp will offset losses from the drop in Flowr Corp's long position.THC Therapeutics vs. Grey Cloak Tech | THC Therapeutics vs. CuraScientific Corp | THC Therapeutics vs. Love Hemp Group | THC Therapeutics vs. Greater Cannabis |
Flowr Corp vs. THC Therapeutics | Flowr Corp vs. Elixinol Global | Flowr Corp vs. Eisai Co | Flowr Corp vs. Mc Endvrs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |